BLMH anticorps (AA 308-400) (Biotin)

N° du produit ABIN1392553

Cet anticorps Lapin Polyclonal détecte spécifiquement BLMH dans WB, ELISA, IHC (p) et IHC (fro). Il présente une réactivité envers Rat et Souris.

Aperçu rapide pour BLMH anticorps (AA 308-400) (Biotin) (ABIN1392553)

Antigène: BLMH (Bleomycin Hydrolase (BLMH))

Reactivité: Rat, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BLMH est conjugé à/à la Biotin

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Détail du produit anti-BLMH anticorps (Biotin)

Épitope: AA 308-400

Réactivité croisée: Souris, Rat

Homologie: Human,Dog,Cow,Sheep,Pig,Horse,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human BLMH

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C for 12 months.

Date de péremption: 12 months

Détails sur BLMH

Antigène: BLMH (Bleomycin Hydrolase (BLMH))

Autre désignation: BLMH

Sujet:

Synonyms: BH, bleomycin hydrolase, BLM hydrolase, BMH, EC 3.4.22.40, BLMH_HUMAN.

Background: Bleomycin hydrolase (BMH) is a cytoplasmic cysteine peptidase that is highly conserved through evolution, however, the only known activity of the enzyme is metabolic inactivation of the glycopeptide bleomycin (BLM), an essential component of combination chemotherapy regimens for cancer. The protein contains the signature active site residues of the cysteine protease papain superfamily. [provided by RefSeq, Jul 2008].